
NRSN
Healthcare · Biotechnology · $3.2M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 30, 2026 | Time not confirmed | -0.04 | 0.00 | +100.0% |
| Mar 25, 2026 | Time not confirmed | -0.11 | 0.00 | +100.0% |
| Nov 26, 2025 | Time not confirmed | -0.06 | -0.04 | +27.3% |
| Aug 1, 2025 | Time not confirmed | -0.23 | -0.19 | +15.6% |
| Apr 7, 2025 | After the close | -0.15 | -0.06 | +60.0% |
| Dec 18, 2024 | Before the open | -0.11 | -0.11 | 0.0% |
| Sep 30, 2024 | After the close | -0.18 | -0.02 | +88.9% |
| Jun 24, 2024 | Before the open | -0.20 | -0.35 | -75.0% |
| Mar 29, 2024 | Before the open | -0.20 | -0.16 | +20.0% |
| Nov 28, 2023 | Before the open | -0.26 | 0.10 | +138.5% |
| Aug 16, 2023 | After the close | -0.28 | -0.44 | -57.1% |
| Jun 1, 2023 | Before the open | -0.29 | -0.33 | -13.8% |
| Mar 22, 2023 | Before the open | -0.28 |
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of…
| -0.27 |
| +3.6% |
| Dec 1, 2022 | Before the open | -0.28 | -0.25 | +10.7% |
| Aug 31, 2022 | Before the open | -0.28 | -0.31 | -10.7% |
| May 31, 2022 | Before the open | -0.18 | -0.24 | -33.3% |
| Mar 2, 2022 | Time not confirmed | -0.16 | -0.16 | 0.0% |
| Dec 10, 2021 | Before the open | -0.21 | -0.25 | -19.0% |
| Jun 30, 2021 | Time not confirmed | 0.00 | -0.27 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.27 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | -0.20 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.20 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.06 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.06 | — |